@rappler: The US Food and Drug Administration approves Wednesday, June 18, Gilead Sciences lenacapavir, a twice-yearly injection, for preventing HIV infection. #hivaids #fyp #rappler
Yeztugo is a twice-yearly injectable medication (generic name: lenacapavir) approved for HIV prevention (PrEP) in HIV-negative individuals. It’s highly effective—over 99.9% prevention rate in trials—and works with just two injections every 6 months after an initial oral+injection startup dose.
⚠️Must test HIV-negative before each dose. Side effects include injection-site reactions, headache, and nausea. It’s not for HIV treatment—misuse can lead to drug resistance.
2025-06-20 17:37:50
0
To see more videos from user @rappler, please go to the Tikwm
homepage.